Jill Murphy, Associate Editor

Consumers using herbal supplements need to be aware of possible adverse effects, respect dosing recommendations, and to consider possible interactions with other medications.

The growth of telehealth during the COVID-19 pandemic has caused health care providers to search for innovative solutions for harder to reach patient populations.

Tea contains flavonoids, which are naturally occurring compounds that have antioxidant properties and provide bioactive compounds that help to neutralize free radicals.

Even before the COVID-19 pandemic, vaccine hesitancy has been a challenge among adult patient populations.

Pharmacists are well suited to help patients overcome the barriers that prevent access to therapy regimens.

It is essential to change the way pharmacists address the needs of diverse populations.

Cytisinicline demonstrated significantly better quit rates than placebo in 6 and 12 week trials.

Study shows high-dose vitamin D, omega-3s, and a simple home strength exercise program led to a cumulative reduction in cancer risk by 61% in healthy adults 70 years of age and older.

Tizlelizumab is a unique anti-PD-1 monoclonal antibody that is being analyzed in 14 pivotal clinical trials across an array of solid tumors.

They added that policy decisions around preventing and treating health conditions is important and should account for the indirect costs of the conditions as well.

Almost all the participants who had not had COVID-19 seroconverted after vaccination, meaning they made antibodies against the virus.

COVID-19 is associated with longer stays in the intensive care unit, which costs nearly twice as much to treat.

Depression can make people who have recovered from COVID-19 feel less enthusiastic in their daily lifestyle.

Conditions such as high blood pressure, diabetes, and obesity may have a significant impact on the likelihood of developing cognitive decline, dementia, and Alzheimer disease.

The results lead to a possible new therapeutic approach to improve immunotherapy outcomes, including combinations with vitamin E, as well as directly targeting SHP1 in dendritic cells.

The CIC is a combination of Novavax’s COVID-19 vaccine, NVX-CoV2373, and its quadrivalent influenza vaccine candidate.

The phase 3, multicenter, randomized, double-blinded, comparative clinical study was evaluating the efficacy and safety of ABP 654 compared with ustekinumab in adult patients with moderate to severe plaque psoriasis.

Additionally, the safety profile in DESTINY-Lung01 was consistent with previous clinical trials with no new safety concerns identified.

The companies have decided to unblind the trial and perform no additional analyses for the OS endpoint because there was no clinical benefit observed in the doublet therapy arm.

The findings, published the New England Journal of Medicine, showed treatment with rilzabrutinib led to a rapid, durable increase in platelet count while supporting an acceptable safety profile.

Investigators focus on understanding the difference in the microenvironments that surround cancer cells in the primary tumor versus the sites where it metastasizes.

Analysis indicates that factors associated with psychological flourishing include being married and physically active, as well as free from chronic pain and anxiety and depression.

Measles elimination is the absence of endemic measles transmission in a region or other defined geographical area for 12 months or longer.

Each vaccine candidate includes 8 mRNAs, which targets both hemagglutinin and neuraminidase at different doses and ratios.

Obesity and a limited physical activity are key factors in post-COVID-19 recovery.

Study captures the immune effect of the third dose of the COVID-19 vaccine in patients with plasma cell disorders and blood cancers.

A recent meta-analysis of statins showed that prevalence of statin intolerance is less than 10%, according to the panel.

Alpelisib is the first FDA-approved treatment for PROS, which is a range of rare conditions characterized by overgrowths and blood vessel anomalies.

Session at American College of Cardiology Scientific Sessions 2022 highlight treatments for symptomatic obstructive hypertrophic cardiomyopathy.

Multiple approaches can be taken to optimize medical therapy in patients with PAD.